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Summary
LKB1 kinase is a tumor suppressor that is causally linked to
Peutz-Jeghers syndrome [1]. In complex with the pseudoki-
nase STRAD and the scaffolding protein MO25, LKB1 phos-
phorylates and activates AMPK family kinases, which
mediate many cellular processes [2, 3]. The prototypical
family member AMPK regulates cell energy metabolism [4]
and epithelial apicobasal polarity [5, 6]. This latter event is
also dependent on E-cadherin-mediated adherens junctions
(AJs) at lateral borders [7, 8]. Strikingly, overexpression of
LKB1/STRAD can also trigger establishment of epithelial
polarity in the absence of cell-cell or cell-matrix contacts
[9]. However, the upstream factors that normally govern
LKB1/STRAD function are unknown. Here we show by immu-
nostaining and fluorescence resonance energy transfer
that active LKB1/STRAD kinase complex colocalizes with
E-cadherin at AJs. LKB1/STRAD localization and AMPK
phosphorylation require E-cadherin-dependent maturation
of AJs. However, LKB1/STRAD complex kinase activity is
E-cadherin independent. These data suggest that in polar-
ized epithelial cells, E-cadherin regulates AMPK phosphory-
lation by controlling the localization of the LKB1 complex.
The LKB1 complex therefore appears to function down-
stream of E-cadherin in tumor suppression.
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LKB1/STRAD Kinase Complex Localizes
at the Level of Adherens Junctions
To investigate regulation of the LKB1/STRAD complex, we first
examined its localization in polarized epithelial cells. Immuno-
stained endogenous LKB1 localized predominantly at cell-cell
junctions in polarized Caco-2 and MDCK II cells (Figures 1A
and 1G). Z axis projections showed that LKB1 staining was
mainly present at adherens junctions, where it colocalized
with E-cadherin. LKB1 was minimal at both the apical domain,
marked by villin, and the basal domain (Figure 1B). Endoge-
nous LKB1 was also poorly localized at tight junctions as
marked by ZO-1 (Figure 1C). To our knowledge, this is the first
report of endogenous LKB1 localization in polarized epithelial
cells.
Previous studies showed a small amount of endogenous
LKB1 in membrane fractions [10]. In other work, overex-
pressed LKB1 distributed between the cytoplasm and nucleus
[10–12]. Those studies proposed that LKB1 was a nuclear
protein that relocalized to the cytoplasm in a STRAD-
dependent manner [2, 11]. Because our immunostaining did
not detect any nuclear LKB1, we analyzed its distribution by
fractionating polarized Caco-2 cells. LKB1 was completely
absent from the nuclear fraction (characterized by histone
H1) but was abundant in the cytosolic and membrane fractions
(characterized by RhoGDI1 and E-cadherin, respectively;
Figure 1D), much like STRADa and the LKB1 substrate
AMPK, as previously described for the latter [13]. We did
observe that overexpressed LKB1 was partially nuclear (see
Figure S2A available online). However, in the polarized or non-
polarized epithelial cell lines that we examined, endogenous
LKB1 was not detected in the nucleus. These cells presumably
have sufficient levels of STRAD to allow endogenous LKB1 to
be constitutively cytoplasmic.
To confirm the immunolocalization, we prepared stable
MDCK clones in which LKB1 was depleted by using small
hairpin RNAs (shRNA). Clones 11 and 14 showed large
decreases in LKB1 at the mRNA (not shown) and protein level
(Figure 1E), whereas E-cadherin and STRAD were unaffected.
Recent papers described in Drosophila a key role for AMPK in
epithelial polarity [5, 6]. We evaluated AMPK phosphorylation
on threonine 172 (AMPK-T172), the site of LKB1 phosphoryla-
tion. Clone 14, in which LKB1 was depleted by w80%,
exhibited anw50% decrease in AMPK-T172 phosphorylation
(Figure 1F). Activation of AMPK by other kinases [14, 15] may
account for this modest discrepancy. AMPK phosphorylation
was rescued by transient transfection of GFP-tagged human
LKB1 wild-type (insensitive to canine shRNA) (Figure 1E; quan-
tified in Figure 1F). In LKB1-depleted cells, staining for LKB1
was also greatly reduced, indicating that the signal was
specific (Figure 1G). Interestingly, E-cadherin and villin ap-
peared less regular after LKB1 suppression, although their
polarity appeared largely unaltered (Figure 1G). Figure S1
shows comparable results in Caco-2 cells with the shRNA
construct described in [9].
Because LKB1 membrane localization was reported to be
dependent on its C-terminal CAAX sequence that serves as
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Figure 1. LKB1 Localizes at Adherens Junction Level in Polarized Epithelial Cells
(A) Polarized Caco-2 stained for LKB1 (green) and E-cadherin (red).
(B and C) X-Z projection of polarized Caco-2 cells stained for LKB1 (green) and villin (red) (B) or for LKB1 (green) and ZO-1 (red) (C).
(D) Polarized Caco-2 cells were fractionated as described in Supplemental Experimental Procedures and analyzed for indicated proteins. Results are
representative of two independent experiments.
(E) MDCK clones stably knocked down for LKB1 (cl) by shRNA or control construct (shLuc) transiently transfected with either GFP alone or GFP-LKB1wt
were analyzed by western blotting for indicated proteins.
(F) AMPKp-172/total AMPK ratio (black bar) was determined and plotted with endogenous (endo, white bar) and exogenous (exo, gray bar) LKB1, all relative
to control. Values are means 6 SD (n = 2).
(G) Polarized MDCK shLuc and shLKB1 cl14 were stained for LKB1 (green), E-cadherin (purple), and villin (red).
Scale bars represent 10 mm.a site for prenylation [10, 16], we localized GFP-tagged WT
LKB1 versus a nonprenylated mutant (LKB1-CA) in MDCK
cells. As described [2, 11] and mentioned above, GFP-LKB1-
WT localized to the nucleus. Similar to endogenous LKB1, it
was also at cell-cell contacts with E-cadherin, but little was
localized to tight junctions (Figure S2A). By contrast, GFP-
LKB1-CA was diffusely distributed in the cytoplasm and the
nucleus, with much less at the membrane (Figures S2B and
S2C). We conclude that in polarized epithelial cells, endoge-
nous LKB1 localizes mainly at adherens junctions, with
membrane association being prenylation dependent.
Because the LKB1 complex includes STRAD and Mo25
[2, 11], we wondered whether STRAD also localized toadherens junctions. We therefore raised a rabbit polyclonal
antibody against the STRADa C terminus. Western blotting
showed that the antibody specifically recognized an endoge-
nous band in MDCK and Caco-2 cells at 45 kDa, which comi-
grated with overexpressed Flag-STRADa (Figure S3A). When
MDCK cells transiently transfected with N-terminally Flag-
tagged STRAD were fixed and stained (Figure S3B), we
observed a bright and diffuse cytoplasmic signal for both
Flag and STRAD in transfected cells, in agreement with
previous reports [2, 11]. By contrast, almost all untransfected
cells exhibited cortical membrane staining. This staining was
completely abolished by an excess of soluble immunogenic
protein, although Flag staining was unaffected. Staining for
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Figure 2. STRAD Localizes with LKB1 at Adherens Junction Level
(A) Polarized MDCK shLuc or shLKB1 cl14 cells were stained for LKB1 (green), E-cadherin (purple), and STRAD (red).
(B) Polarized Caco-2 clone knocked down for LKB1 (cl A12) or not (shLuc) were fractionated as in Figure 1.
(C) Membranous shLKB1 cl A12/shLuc ratio for LKB1, STRADa, and total or phosphorylated AMPK, normalized to E-cadherin. Values are means 6 SD
(n = 3).
(D) MDCK cells on fibronectin-coated coverslips were transiently transfected with YFP-STRADa (yellow) plus either CFP-Myr, wild-type, or SL26 CFP-LKB1
(blue). FRET was measured as described in the Supplemental Experimental Procedures. The asterisk marks an unidentified perinuclear compartment.
(E) Projections of FRET images from CFP-LKB1-WT and YFP-STRADa. FRET intensity is displayed on a pseudocolor scale in arbitrary units.
Scale bars represent 10 mm.endogenous STRADa, LKB1, and E-cadherin in polarized
Caco-2 (Figure S1E) or MDCK cells (Figure 2A, shLuc) showed
that these proteins substantially colocalized. As with endoge-
nous LKB1, almost no STRAD signal was detected at tight
junctions (not shown) or at the apical domain (Figures S1E
and S2A, shLuc). Importantly, LKB1-depleted cells exhibited
mainly cytoplasmic STRADa staining, suggesting that STRAD
localization at adherens junctions depends on LKB1. After
fractionation of control, shLuc or LKB1-depleted Caco-2 cells
showed decreased STRADa in the membrane (Figures 2B and
2C). Total STRADa expression and AMPK distribution were
unaffected. These results show that in polarized epithelial
cells, STRADa localizes at adherens junctions in an LKB1-
dependent manner.
Active LKB1/STRAD Kinase Complex at Adherens
Junctions
Whether LKB1 at adherens junctions is bound to STRAD is an
important question because this interaction is required for
LKB1 kinase activity [2, 11]. We therefore evaluated theproximity of LKB1 and STRADa by using fluorescence reso-
nance energy transfer (FRET), which provides higher spatial
resolution than colocalization. LKB1 and STRAD were tagged
with CFP and YFP, respectively. As a negative control, we
used the SL26 LKB1 mutation, isolated from a Peutz-Jeghers
patient [17], which does not bind STRAD [11]. We also used
CFP fused to the Fyn kinase myristoylation and palmitoylation
membrane localization sequence (CFP-Myr) [18]. These
constructs expressed equally well in MDCK cells (Figure S4A).
As expected, YFP-STRAD coimmunoprecipitated (IPed) with
WT CFP-LKB1 but not with SL26 LKB1, CFP-Myr, or CFP alone
after immunoprecipitating LKB1 with limiting antibody to mini-
mize IP of endogenous LKB1 (Figure S4B). YFP-STRAD co-IP
was observed by probing with an anti-GFP antibody or with
anti-STRAD sera. Next, we analyzed these precipitates for
LKB1 kinase activity by using a recombinant AMPK fragment
and probing for phospho-T172 [19]. LKB1 kinase activity was
elevated only when WT LKB1 and STRAD were coexpressed,
whereas all other conditions showed poor kinase activity
(Figure S4B). As previously reported [10–12], high LKB1 kinase
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40activity was associated with a shift in the LKB1 band to lower
mobility, which was attributed to serine/threonine autophos-
phorylation, providing further evidence for activation. In the
absence of transfected LKB1, endogenous LKB1 showed little
kinase activity and no detectable associated YFP-STRAD at
these exposures. Thus, endogenous LKB1 makes a negligible
contribution compared to the transfected protein under these
conditions.
FRET was assessed in cells transfected with YFP-STRAD
plus CFP-LKB1 or controls (Figure 2D). Substantial FRET was
observed when WT constructs were coexpressed, whereas
minimal FRET was detected with CFP-LKB1-SL26 or CFP-
Myr (Figure 2D). FRET was highest at lateral membranes,
indicating that LKB1 and STRAD are within w5 nm in this
compartment. Little FRET was detected at apical or basal
domains, as shown in the Z axis projections (Figure 2E). We
also observed increased membrane localization of STRAD
when coexpressed with WT LKB1 but not SL26 LKB1
(Figure 2D). Some cells showed accumulation of both probes
at a perinuclear localization where FRET was high (cf. Figure 2D,
asterisk). This location was not evident with endogenous
proteins and was not further evaluated. As a further control,
FRET was tested by acceptor photobleaching [20] (Figure S4D),
which showed that after YFP-STRAD was bleached, CFP-LKB1
intensity inside the bleached area increased w8% when
normalized to the unbleached control area. These data are
consistent with a physical interaction between LKB1 and
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Figure 3. E-Cadherin Is Required to Localize
LKB1 at Adherens Junction
(A) MDCK cells expressing control (shLuc) or
E-cadherin (shE-cad) shRNA vectors were
analyzed by western blot for indicated proteins.
(B) Cells were stained for LKB1 (green) and
E-cadherin (red). Scale bars represent 10 mm.
(C) MDCK cells described in (A) were fractionated
as described in Figure 1.
(D) Ratio of membranous shE-cad/shLuc of
LKB1, STRADa, and total or phosphorylated
AMPK, normalized to integrin. Values are
means 6 SD (n = 2).
STRAD at cell-cell junctions, suggesting
that LKB1 kinase is likely to be active at
this location.
LKB1/STRADa Recruitment
to Adherens Junction
Depends on E-Cadherin
To test whether lateral LKB1/STRADa
localization is dependent on E-cadherin,
we stably depleted E-cadherin in MDCK
cells by using a previously described
shRNA [21]. Knockdown efficiency
determined by western blotting was
w90% (Figure 3A), whereas LKB1 and
STRADa expression levels were not
affected. In these cells, LKB1 immunos-
taining at cell-cell junctions decreased
concomitant with loss of E-cadherin
(Figure 3B). Similar results were also
observed with transient E-cadherin
knockdown (not shown). Fractionation
of these cells showed that loss of E-
cadherin led to decreased LKB1 and STRADa at the
membrane (Figures 3C and 3D). As a further test, we examined
human colon carcinoma SW480 cells that express very little E-
cadherin, and two stably transfected SW480 clones that
express higher levels of E-cadherin [22]. Membrane localiza-
tion of transiently transfected GFP-LKB1 was minimal in
SW480 cells but increased in E-cadherin-overexpressing
clones SW6A2 and SW8C1 (Figures S5A–S5C). GFP alone
showed only slight membrane localization. Taken together,
these data show that LKB1/STRADa lateral membrane locali-
zation in epithelial cells requires E-cadherin. However, the
fact that E-cadherin adherens junction formation occurs earlier
than LKB1 membrane localization (Figure S5D) suggests that
E-cadherin ligation alone is not sufficient for LKB1 recruitment.
E-Cadherin Effects on LKB1/STRAD Kinase Activity
and Function
Because MDCK cells depleted for E-cadherin had decreased
AMPK-T172 phosphorylation (Figure 3), we analyzed AMPK
activity in these cells. Transient transfection with E-cadherin
shRNA led to a time-dependent decrease of E-cadherin over
72 hr, whereas LKB1, STRAD, and AMPK levels were
unchanged (Figures 4A and 4B). AMPK T172 phosphorylation
decreased as well. However, when LKB1 was IP-ed and kinase
activity was assessed in vitro, no change in kinase activity was
observed (Figures 4C and 4D). Re-expression of shRNA-resis-
tant human E-cadherin restored AMPK phosphorylation
E-Cadherin Regulates LKB1
41(Figures 4E and 4G) without increasing LKB1 intrinsic kinase
activity (Figures 4F and 4G). This effect was LKB1 dependent
because E-cadherin had no further effect on AMPK phosphor-
ylation in stable MDCK LKB1 knockdown cells (Figure 4H).
Taken together, these results show that E-cadherin controls
LKB1-dependent AMPK phosphorylation without a detectable
effect on LKB1/STRAD complex intrinsic kinase activity.
In conclusion, we show that the active LKB1/STRADa kinase
complex localizes to adherens junctions in an E-cadherin-
dependent manner in epithelial cells, which promotes phos-
phorylation of the LKB1 substrate AMPK. However, available
evidence does not suggest a direct physical connection
between E-cadherin and LKB1. LKB1 localization coincides
with junctional maturation rather than initial formation.
Maturation requires E-cadherin but clearly involves other
components. Additionally, localization to cell-cell junctions
requires LKB1 prenylation, which argues against a high-affinity
interaction. Thus, further work will be required to elucidate the
mechanism by which LKB1 targets cell-cell contacts and other
potential locations.
Activated AMPK was recently described to promote epithe-
lial polarity in Drosophila [5, 6] and to negatively regulate the
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Figure 4. E-Cadherin Knockdown Decreases
AMPK Activation
(A) MDCK cells were transiently transfected with
control (shLuc) or shRNA targeting canine E-cad-
herin (shE-cad). Cells were extracted at indicated
times and analyzed by western blot for indicated
proteins.
(B) T172 AMPK phosphorylation and E-cadherin
levels were quantified and normalized to total
AMPK. Values are percent relative to levels in
shLuc or shE-cad cells at 24 hr (means 6 SD;
n = 3). pAMPK, white bars; E-cadherin, black bars.
(C) The same lysates were immunoprecipitated
with anti-LKB1 and kinase activity was analyzed
in vitro (IVK).
(D–G) Kinase activity was quantified and normal-
ized to total immunoprecipitated LKB1, plotted
as described in (B) (means 6 SD; n = 4). Control
(shLuc) and E-cadherin-depleted MDCK cells
were transiently transfected or not with wild-
type human E-cadherin (pcDNAhE-cad). After 24
hr, cells were extracted and treated as in (A) and
(C) ([E] and [F], respectively) and quantified (G).
T172 AMPK phosphorylation in cells, white bar;
LKB1 IP kinase activity (TK), black bar; the mock
transfected control shLuc sample was used as
reference (means 6 SD; n = 3).
(H) Stable control (shLuc) and LKB1-depleted
(shLKB cl14) MDCK cells were transiently
transfected or not with shRNA targeting canine
E-cadherin (shE-cad). After 72 hr, cells were
lysed and analyzed by western blotting with the
specified antibodies (n = 2).
mTOR pathway [15], which is often upre-
gulated in human tumors. Loss of E-cad-
herin in cancer is associated with poor
prognosis through increased metastasis,
although the mechanisms remain incom-
pletely defined [23, 24]. Signaling through
the Wnt/b-catenin pathway clearly
contributes, as do other transcriptional
pathways [23, 25]. Moreover, direct inhi-
bition of cell migration by E-cadherin-
dependent adhesion may also be involved. However, these
effects may not fully explain the link to cancer. Given the known
tumor suppressor activity of LKB1 and its role in promoting
metastases [1, 26, 27], our results predict that loss of E-cad-
herin may promote tumorigenesis in part through inhibition of
LKB1 function, which would lead to increased mTOR activity
as well as contributing to the loss of polarity. Future work is
warranted to test this hypothesis, better define the mecha-
nisms regulating LKB1 localization by E-cadherin, and explore
its role in human cancers.
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures and
five figures and can be found with this article online at http://www.
current-biology.com/supplemental/S0960-9822(08)01550-9/.
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